# Sapphire 3 CTO Study

> **NCT06358508** · NA · COMPLETED · sponsor: **OrbusNeich** · enrollment: 170 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Disease
- Myocardial Ischemia
- Heart Diseases
- Arteriosclerosis
- Cardiovascular Diseases
- Chronic Total Occlusion
- Chronic Total Occlusion of Coronary Artery

## Interventions

- **DEVICE:** Sapphire 3 Coronary Dilatation Catheter

## Key facts

- **NCT ID:** NCT06358508
- **Lead sponsor:** OrbusNeich
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-06
- **Primary completion:** 2025-10-21
- **Final completion:** 2025-10-21
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06358508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06358508, "Sapphire 3 CTO Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06358508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*